[18F]PSMA-11

N/A

Report date: 2025/11/19 17:58:20

NME

Base Information

Drug Name[18F]PSMA-11

Drug Alias NameF-18 PSMA-1118F-PSMA-11[18F]-AlF-PSMA-11[18F]AlF-PSMA-11

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionProstate-Specific Membrane Antigen modulators

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic NeoplasmsThyroid Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesGhent University Hospital

China Registration ClassN/A

Develop Information

Active CompaniesGhent University Hospital

Inactive CompaniesN/A

Active IndicationsThyroid Neoplasms

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A